Clinical Trials Sponsored by Sinotau Pharmaceutical Group

Total 683 results

Sihuan Pharmaceutical Holdings Group Ltd.

Unknown

Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin

Diabetes Mellitus, Type 2

China
Sihuan Pharmaceutical Holdings Group Ltd.

Unknown

Janagliflozin Treat T2DM Monotherapy

Diabetes Type 2

China
Sihuan Pharmaceutical Holdings Group Ltd.

Completed

A Multiple Ascending High Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects

Healthy Volunteers

China
Sihuan Pharmaceutical Holdings Group Ltd.

Unknown

Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth

Healthy Male Volunteers
Promomed, LLC
Solyur Pharmaceuticals Group

Completed

Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19

COVID-19

Russian Federation
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Not yet recruiting

A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A

Hemophilia A

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

A Clinical Study of TQH2929 in Healthy Adult Subjects

Psoriasis

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer

Breast Cancer

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.

Sinusitis

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors

Hematological Tumors

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Terminated

Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade Sarcoma

Advanced High-grade Sarcoma

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers

Advanced Cancer

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.

Diabetes Mellitus, Type 2

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Mantle Cell Lymphoma

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Not yet recruiting

Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers

Advanced Cancer

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Not yet recruiting

Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant Tumors

Advanced Tumors

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors

Advanced Malignant Tumor

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Terminated

A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma

Pancreatic Carcinoma

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

A Clinical Trial of TQH3906 Capsules in Healthy Volunteers

Psoriasis

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

Clinical Trial Evaluating the Safety of the TQB2103 for Injection

Advanced Malignant Neoplasm

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects

Atopic Dermatitis

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

Clinical Trial of the TQB2930 Injection in Patients With Advanced Cancers

Advanced Cancers

China
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers

Advanced Cancer

China
Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Recruiting

Phase 1 Study of KH607 Tablets

Healthy

China
Guizhou Bailing Group Pharmaceutical Co Ltd

Completed

Kesuting Syrup in the Treatment of Corona Virus Disease 2019 (COVID-19)

Cough | COVID-19 Pneumonia

China
Guizhou Bailing Group Pharmaceutical Co Ltd

Completed

The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis

General Disorders and Administration Site Conditions

China
Yangtze River Pharmaceutical Group Co., Ltd.

Completed

A Study of the Interaction of Tunodafil Hydrochloride Tablets and Alcohol

Erectile Dysfunction

China
Vanguard Research Group
Otsuka America Pharmaceutical

Completed

Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics (PRELAPSE)

Schizophrenia

United States
Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Unknown

Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition

Bioequivalence

China
Guizhou Bailing Group Pharmaceutical Co Ltd

Active, not recruiting

Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy

Diabetic Retinopathy | Type2 Diabetes

China
Maoxiang Group Jilin Pharmaceutical Co., Ltd.

Completed

The Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

China
Novartis Pharmaceuticals
Children's Oncology Group

Recruiting

Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients (CASSIOPEIA)

B-Cell Acute Lymphoblastic Leukemia

United States, Belgium, Italy, Sweden, Netherlands, Norway, United Kingdom, Germany, Canada, Spain, France, Finland, Denmark
Sermonix Pharmaceuticals Inc.
Linical Accelovance Group

Active, not recruiting

Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Locally Advanced or Metastatic Breast Cancer

United States, Canada, Israel
Midland Research Group, Inc.
Janssen Pharmaceuticals

Terminated

Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita) (SymITA)

Human Immunodeficiency Virus

United States
Spanish Lung Cancer Group
Aventis Pharmaceuticals

Completed

Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer (GECP0008)

Non Small-cell Lung Cancer
NCIC Clinical Trials Group
Ariad Pharmaceuticals

Completed

Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer

Endometrial Cancer

Canada
NCIC Clinical Trials Group
Nexstar Pharmaceuticals

Completed

Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada
Canadian Cancer Trials Group
Jazz Pharmaceuticals

Recruiting

Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma

Gastroesophageal Adenocarcinoma

Canada
Jazz Pharmaceuticals
Children's Oncology Group (COG)

Completed

An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)

Acute Lymphoblastic Leukemia | Lymphoblastic Leukemia

United States, Canada
Price Vision Group
Kala Pharmaceuticals, Inc.

Completed

Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection

Corneal Edema | Corneal Endothelial Dystrophy

United States
Novartis Pharmaceuticals
Children's Oncology Group

Completed

Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors

Solid Tumours

United States, Canada, Hungary, Spain, France, Slovakia, Czechia
Koffler Vision Group
Fera Pharmaceuticals, LLC

Terminated

Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Kennedy Medical Group
Teva Pharmaceuticals USA

Terminated

Efficacy and Safety of Cyclobenzaprine Hydrochloride Extended Release for the Treatment of Chronic Migraine

Chronic Migraine

United States
Haisco Pharmaceutical Group Co., Ltd.
Haisco Pharmaceutical(Australia) Pty Ltd.

Completed

A Study of Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosed of HSK31858 in Healthy Volunteers

Healthy

Australia
Xizang Haisco Pharmaceutical Co., Ltd

Active, not recruiting

Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.

Healthy

China
Xizang Haisco Pharmaceutical Co., Ltd

Recruiting

A Study for HSK39775 in Participants With Solid Tumors

Advanced Solid Tumors

China
Xizang Haisco Pharmaceutical Co., Ltd

Not yet recruiting

A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.

Pruritus
Chinese SLE Treatment And Research Group
CHENLIJI Pharmaceutical Company,Guangzhou Pharmaceutical Group; CHINESE RHEUMATISM...

Unknown

Kunxian for the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

China
Novartis Pharmaceuticals
Breast International Group; German Breast Group; SOLTI Breast Cancer Research...

Completed

NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer (NeoPHOEBE)

HER2-positive Newly Diagnosed, Primary Breast Cancer

Austria, Spain, Australia, Germany
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors

Advanced Cancers

China

Clinical Trials Sponsored by Sinotau Pharmaceutical Group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations